Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Athira Pharma Announces Appointment of Kelly A. Romano to its Board of Directors
07:30am, Monday, 14'th Dec 2020
SEATTLE, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop
Athira Pharma wins $15M grant for clinical trial of Alzheimer's drug from National Institute on Aging
10:48am, Tuesday, 08'th Dec 2020
Seattle-based biotech company Athira Pharma announced a three-year grant totaling $15 million from the National Institute on Aging to support an upcoming clinical trial of a treatment that seeks to st
Athira Pharma Awarded $15 Million Grant from National Institute on Aging to Support ACT-AD Clinical Trial in Alzheimer's Disease
07:30am, Tuesday, 08'th Dec 2020
SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop
SEATTLE, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop
Athira Pharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights
04:05pm, Thursday, 12'th Nov 2020
- LIFT-AD clinical trial evaluating ATH-1017, a once-daily investigational drug for the treatment of mild-to-moderate Alzheimer's disease, actively enrolling
Athira Pharma to Present at Upcoming November Investor Conferences
07:30am, Tuesday, 10'th Nov 2020
SEATTLE, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop
Athira Pharma Seeks $160 Million To Advance Alzheimer's Treatment
04:29pm, Monday, 14'th Sep 2020
Athira Pharma has filed proposed terms for its $160 million IPO. The firm is developing treatments for Alzheimer's and Parkinson's diseases and other neurological conditions.
